Release
📈 Stocks
Ribo Life Science Files EU Clinical Trial Application for siRNA Drug SR122
(11 hours ago)
Ribo Life Science advances its lipid-disorder pipeline with an EU Phase I trial application for SR122, a dual-target siRNA candidate targeting ApoC3…